Organicell OTC Stock Performance

OCEL
 Stock
  

USD 0.027  0.002  6.90%   

Organicell Regenerative holds a performance score of 8 on a scale of zero to a hundred. The company holds a Beta of 0.3681, which implies possible diversification benefits within a given portfolio. Let's try to break down what Organicell's beta means in this case. As returns on the market increase, Organicell Regenerative returns are expected to increase less than the market. However, during the bear market, the loss on holding Organicell Regenerative will be expected to be smaller as well. Although it is vital to follow Organicell Regenerative current trending patterns, it is good to be conservative about what you can do with the information regarding equity existing price patterns. Our philosophy towards forecasting future performance of any stock is to look not only at its past charts but also at the business as a whole, including all fundamental and technical indicators. To evaluate if Organicell Regenerative expected return of 1.19 will be sustainable into the future, we have found twenty-one different technical indicators, which can help you to check if the expected returns are sustainable. Use Organicell Regenerative information ratio, as well as the relationship between the value at risk and expected short fall to analyze future returns on Organicell Regenerative.
  
Organicell Performance
8 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Organicell Regenerative Medicine are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak technical and fundamental indicators, Organicell Regenerative revealed solid returns over the last few months and may actually be approaching a breakup point. ...more

Structure and Payout Changes

Last Split Factor
18:1
Last Split Date
2015-09-21

Organicell Price Channel

Quick Ratio0.02
Fifty Two Week Low0.0100
Fifty Two Week High0.1100

Organicell Regenerative Relative Risk vs. Return Landscape

If you would invest  2.00  in Organicell Regenerative Medicine on May 11, 2022 and sell it today you would earn a total of  0.90  from holding Organicell Regenerative Medicine or generate 45.0% return on investment over 90 days. Organicell Regenerative Medicine is currently generating 1.1929% in daily expected returns and assumes 11.0427% risk (volatility on return distribution) over the 90 days horizon. In different words, 95% of otc stocks are less volatile than Organicell, and 78% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Organicell Regenerative is expected to generate 8.7 times more return on investment than the market. However, the company is 8.7 times more volatile than its market benchmark. It trades about 0.11 of its potential returns per unit of risk. The DOW is currently generating roughly 0.05 per unit of risk.

Organicell Regenerative Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Organicell Regenerative's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Organicell Regenerative Medicine, and traders can use it to determine the average amount a Organicell Regenerative's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.108

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsOCEL
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 11.04
  actual daily
 
 95 %
of total potential
 
9595
Expected Return
 1.19
  actual daily
 
 22 %
of total potential
 
2222
Risk-Adjusted Return
 0.11
  actual daily
 
 8 %
of total potential
 
88
Based on monthly moving average Organicell Regenerative is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Organicell Regenerative by adding it to a well-diversified portfolio.

About Organicell Regenerative Performance

To evaluate Organicell Regenerative OTC Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Organicell Regenerative generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Organicell OTC Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Organicell Regenerative stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Organicell's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida. Organicell Regenerative operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 22 people.

Things to note about Organicell Regenerative

Checking the ongoing alerts about Organicell Regenerative for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Organicell Regenerative help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Organicell Regenerative Alerts

Equity Alerts and Improvement Suggestions

Organicell Regenerative is way too risky over 90 days horizon
Organicell Regenerative has some characteristics of a very speculative penny stock
Organicell Regenerative appears to be risky and price may revert if volatility continues
The company currently holds 1.3 M in liabilities with Debt to Equity (D/E) ratio of 22.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Organicell Regenerative has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Organicell Regenerative until it has trouble settling it off, either with new capital or with free cash flow. So, Organicell Regenerative's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Organicell Regenerative sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Organicell to invest in growth at high rates of return. When we think about Organicell Regenerative's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 6.37 M. Net Loss for the year was (5.52 M) with profit before overhead, payroll, taxes, and interest of 5.05 M.
Organicell Regenerative Medicine currently holds about 66 K in cash with (1.62 M) of positive cash flow from operations.
Roughly 48.0% of Organicell Regenerative outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Organicell Regenerative exotic insider transaction detected
Please check Your Equity Center. Note that the Organicell Regenerative information on this page should be used as a complementary analysis to other Organicell Regenerative's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Organicell OTC Stock analysis

When running Organicell Regenerative price analysis, check to measure Organicell Regenerative's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organicell Regenerative is operating at the current time. Most of Organicell Regenerative's value examination focuses on studying past and present price action to predict the probability of Organicell Regenerative's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Organicell Regenerative's price. Additionally, you may evaluate how the addition of Organicell Regenerative to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Is Organicell Regenerative's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organicell Regenerative. If investors know Organicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organicell Regenerative listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
31.5 M
Quarterly Revenue Growth YOY
0.45
Return On Assets
-1.86
The market value of Organicell Regenerative is measured differently than its book value, which is the value of Organicell that is recorded on the company's balance sheet. Investors also form their own opinion of Organicell Regenerative's value that differs from its market value or its book value, called intrinsic value, which is Organicell Regenerative's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organicell Regenerative's market value can be influenced by many factors that don't directly affect Organicell Regenerative's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organicell Regenerative's value and its price as these two are different measures arrived at by different means. Investors typically determine Organicell Regenerative value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organicell Regenerative's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.